Mayo Clinic's Stephanie Faubion says observational data on 2,400 women shows hormone therapy helps menopausal GLP-1 users catch up with peers. She also warns off compounded versions.
Recap by typeshit. Full story at AARP.
A brief Facebook post says a daily pill might help people who worry about putting weight back on once they come off Wegovy. It names no drug or study.
In 367 adults with type 2 diabetes, the top combo dose beat 14.8% on tirzepatide alone at 48 weeks. Lilly plans phase 3 by late 2026.
Alessandro Sette's lab will track T cell responses in people before and after starting GLP-1s, including to Parkinson's-linked proteins. He is enrolling himself too.
12:35
Dr. Eric Berg walks through the basics of peptides in a broad explainer. Treat any health claims as his own views.
Only 493 people across eight small trials. The two with the most weight loss, on semaglutide and high-dose liraglutide, both reported lower spine and hip bone density.
Roy's sources point to Case Western research using health records of 1,094,761 adults with type 2 diabetes, reporting a 0.33 hazard ratio for semaglutide versus insulin.
Loading…